| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,747 | 10,465 | 5,829 | 12,190 | | Cost of Revenue | 1,625 | 6,312 | 3,346 | 7,247 | | | Gross Profit | 1,122 | 4,153 | 2,483 | 4,943 | | | Operating Expenses | | Research Development | 422 | 554 | 418 | 702 | | Selling General and Administrative | 2,295 | 4,395 | 3,073 | 3,815 | | Non Recurring |
-
| 176 | 2 | 100 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,595) | (972) | (1,011) | 326 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 181 | 329 | 138 | 126 | | Earnings Before Interest And Taxes | (1,414) | (643) | (836) | 416 | | Interest Expense | 28 | 93 | 62 | 93 | | Income Before Tax | (1,442) | (736) | (899) | 323 | | Income Tax Expense | (246) | 56 | (675) | 146 | | Minority Interest | (28) | (11) | 3 | (20) | | | | Net Income From Continuing Ops | (1,197) | (804) | (256) | 194 | | | Non-recurring Events | | Discontinued Operations | 252 | 2,981 | 372 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (944) | 2,177 | 115 | 194 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($776) | $2,177 | $115 | $194 |
|
0.02% Nasdaq 
Income Statement
